殊途同归1突破性的高科技发明: By exploring the processing opportunities from biopolymer low crystallization rates, desirable performances of biomedical devices can be made directly from the attributes of biopolymers and tuned from the in-situ incorporation of additives through minimized steps and mild parameters during the biomedical device sizing and forming steps.
殊途同归1突破性发现发明的Impact: If successful, products with overall desirable performance/price ratios can be made from biopolymers at the economic scale. Biopolymers will be irreplaceable in bio and controlled release applications.
殊途同归1 发表评论于
殊途同归1突破性的发现: Biopolymers demonstrate low crystallization rates during and after processing. This phenomenon reveals macroscopic behaviors of activating quantum particle interactions under mild parameters. These quantum interactions have certain macroscopic behaviors under mild parameters. After activated and forced, materials are still activated and opened even under mild parameters during and after processing. These macroscopic behavior and quantum interaction provide biopolymers their unique and attributed processing opportunities.
殊途同归1突破性的高科技发明: By exploring the processing opportunities from biopolymer low crystallization rates, desirable performances of biomedical devices can be made directly from the attributes of biopolymers and tuned from the in-situ incorporation of additives through minimized steps and mild parameters during the biomedical device sizing and forming steps.
殊途同归1突破性发现发明的Impact: If successful, products with overall desirable performance/price ratios can be made from biopolymers at the economic scale. Biopolymers will be irreplaceable in bio and controlled release applications.
加州大学洛杉矶分校（UCLA）梁京教授团队发明治疗阿尔茨海默症的新药。
如本文引述闵宝权医生所说，目前治疗阿尔茨海默症并没有直接有效的药，只能缓解其症状，不能根治。的确，目前FDA批准的治疗阿尔茨海默症的药物，都只能暂时缓解症状。梁京教授团队发明的新药的重大意义在于，它不但能改善失忆，改善认知障碍等症状，还能逆转该病的病理过程（reverse the neuropathology），就是说，有望能够根治。这种药物在小鼠模型上实验成功。论文发表在今年六月的神经化学研究杂志（Neurochemical Research）。不是很牛的杂志，有时候很牛的论文会发表在一般的期刊上。有些人不大重视杂志的排名。